The Importance of Home Blood Pressure Measurement for Preventing Stroke and Cardiovascular Disease in Hypertensive Patients : A Sub-Analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) Study, a Prospecti

スポンサーリンク

概要

• 論文の詳細を見る
• 2008-10-01

著者

• Shimamoto Kazuaki

  Sapporo Medical University School of Medicine

• OGIHARA Toshio

  Osaka University

• FUJITA Toshiro

  University of Tokyo

• ITO Sadayoshi

  Tohoku University

• SHIMADA Kazuyuki

  Jichi Medical University

• 伊藤 貞嘉

  東北大学病院 腎高血圧内分泌科

• Fujita Takayuki

  Department Of Geriatric Medicine Osaka University Graduate School Of Medicine

• Itoh Sadayoshi

  Tohoku University

• Ito Sadayoshi

  Division Of Nephrology Endocrinology And Vascular Medicine Department Of Medicine Tohoku University

• Shimamoto Kazuaki

  大阪大学 医学系研究科老年内科

• YOSHIIKE Nobuo

  National Institute of Health and Nutrition

• Iimuro Satoshi

  筑波大学 臨床医学系内科

• Iimuro Satoshi

  Department Of Biostatistics School Of Public Health The University Of Tokyo

• Ito Sadayoshi

  Division Of Nephrology Hypertension And Endocrinology Department Of Medicine Tohoku University Gradu

• Sugimura Kohichiro

  東北大学 医学系研究科循環器病態学分野

• Fujita Toshiro

  Department Of Geriatric Medicine Osaka University Graduate School Of Medicine

• Obara Taku

  東北大学 臨床薬学

• Okuda Tomohiko

  国立循環器病センター研究所 疫学部

• Shimamoto Kazuaki

  帝京大学 医学部内科

• Naritomi Hiroaki

  National Cardiovascular Center

• Tanaka Heizo

  Koshien University

• Shimamoto Kazuaki

  Second Department Of Internal Medicine Sapporo Medical College

• Ogihara Toshio

  Osaka General Medical Center

• Ito Sadayoshi

  Department Of Nephrology Endocrinology And Hypertension Tohoku University School Of Medicine

• Ojima Toshiyuki

  Hamamatsu Univ. School Of Medicine

• Okubo Takayoshi

  Department Of Planning For Drug Development And Clinical Evaluation Tohoku University

• Ito Sadayoshi

  岡山大学 大学院医歯薬学総合研究科腎･免疫･内分泌代謝内科学

• Tochikubo Osamu

  The Second Department Of Internal Medicine Yokohama City University

• Shimamoto Kazuaki

  The 2nd Department Of Internal Medicine Sapporo Medical University School Of Medicine

• Okura Takafumi

  Department Of Planning For Drug Development And Clinical Evaluation Tohoku University

• Fujimori Takahiro

  Department Of Pathology Division Of Hypertension And Cardiorenal Disease Dokkyo University School Of

• Fujita Toshiro

  University Of Tokyo Graduate School Of Medicine

• Shimada Kazuyuki

  The Departments Of Cardiology Echi Medical School

• Ogihara T

  Osaka Univ. Medical School Osaka Jpn

• Ito Sadayoshi

  Department Of Biostatistics School Of Public Health The University Of Tokyo

• SHIMAMOTO Kazuaki

  Sapporo Medical University

関連論文

• Relationship Between Coronary Events and Serum Cholesterol During 10 Years of Low-Dose Simvastatin Therapy : Long-Term Efficacy and Safety in Japanese Patients With Hypercholesterolemia in the Japan Lipid Intervention Trial (J-LIT) Extension 10 Study, a P
• 術後下垂体機能が回復したACTH産生下垂体 macroadenoma による Cushing 病の一例
• Relationship Between Coronary Events and Serum Cholesterol During 10 Years of Low-Dose Simvastatin Therapy : Long-Term Efficacy and Safety in Japanese Patients With Hypercholesterolemia in the Japan Lipid Intervention Trial (J-LIT) Extension 10 Study, a P
• The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension
• Relationship Between Coronary Events and Serum Cholesterol During 10 Years of Low-Dose Simvastatin Therapy : Long-Term Efficacy and Safety in Japanese Patients With Hypercholesterolemia in the Japan Lipid Intervention Trial (J-LIT) Extension 10 Study, a P
• 薬剤性糸球体疾患について知っておくべきこと (特集 糸球体疾患--腎炎からネフローゼまで,最高の診療を目指して) -- (薬物療法の注意点)
• アンジオテンシン2と微小循環障害 (特集 レニン・アンジオテンシン・アルドステロン系の進歩) -- ((プロ)レニン/アンジオテンシンと受容体の分子生物学)
• Accumulation of common polymorphisms is associated with development of hypertension : a 12-year follow-up from the Ohasama study
• A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension : the REZALT study
• Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats
• Effects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease : subanalysis of the CASE-J Study
• Effects of Cardiac Complications on Cardiovascular Events in Japanese High-Risk Hypertensive Patients : Subanalysis of the CASE-J Trial
• Fas promoter region gene polymorphism is associated with an increased risk for myocardial infarction
• Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications : a sub-analysis of the CASE-J trial
• 高血圧自然発症ラットの腎 20-hydroxyeicosatetraenoic acid 産生におけるアンドロゲンの役割
• 慢性腎臓病(CKD)ステージ5患者の治療同意能力に関する予備的検討
• アルドステロン産生腫瘍の多発性の検討 : 副腎部分切除術の妥当性についての考察
• 両側副腎にアルドステロン産生微小腺腫を伴ったクッシング症候群の一例
• 急性心不全を契機に診断したコルチゾル・テストステロン産生副腎皮質腺腫の一例
• ACTH負荷副腎静脈サンプリングにて確定診断したデオキシコルチコステロン(DOC)産生腫瘍の1例
• ^Inオクトレオタイドスキャンにて確定診断のついた気管支カルチノイドによる異所性ACTH症候群の1例
• 原発性アルドステロン症診断のクリニカルパスとACTH負荷両側副腎静脈血同時採血法(原発性アルドステロン症におけるACTH負荷副腎静脈サンプリングの意義,第2回副腎静脈サンプリング研究会,プロシーディングス)
• Cushing病の治療と長期予後および治癒判定基準 - 下垂体手術, gamma knife療法および薬物療法 -
• 下垂体手術治療後に preclinical Cushing 症候群が明らかとなった機能性右副腎皮質腫瘍合併 Cushing 病の1例
• 5.血漿交換(PE)継続施行が有効であった若年性関節リウマチ(JRA)の1例(一般演題,日本アフェレシス学会第18回東北アフェレーシス研究会抄録)
• 30 全身性エリテマトーデス(SLE)患者へのplasmapheresis施行後の急性肺水腫の発症とその背景因子、血行動態の変化についての検討
• 0703 マクロファージ及び血管壁におけるPPAR-γactivatorによるトロンボキサン合成酵素遺伝子の転写性発現調節機構
• Na代謝異常:Gitelman's syndromeとNaトランスポーター遺伝子異常
• Clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease
• 尿量コントロールにhydrochrolothiazideがイ効であった腎性尿崩症の1例
• Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial
• Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient
• Chronic Kidney Disease Japan Cohort (CKD-JAC) Study : Design and Methods
• Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease
• 1 Which Risk Factor Has an Adverse Effect on Coronary Events in Japanese High-risk Hypertensive Patients? : a Subanalysis of CASE-J(Comprehensive Risk Management for Prevention of Coronary Artery Disease,Symposium 16 (SY-16) (H),The 73rd Annual Scientific
• 診療ガイドラインに基づく病期別治療方針 (糖尿病性細小血管症(第2版)--発症・進展制御の最前線) -- (糖尿病性腎症)
• 4 On-going Japanese Clinical Trials for Hypertension II : Seeking for More Effective Pharmacological Treatment(ESC-JCS Joint Symposium (ESC-JCS Joint Symposium) (H) Evidence-Based Medical Treatment of Hypertension,Special Program,The 72nd Annual Scientifi
• Mechanisms that control glomerular hemodynamics
• アンジオテンシンIIによる腎髄質機能調節
• Adrenoleukodystrophy (特集 副腎不全--診断と治療の進歩) -- (原発性副腎機能低下症の診断)
• 1 Which Risk Factor Has an Adverse Effect on Coronary Events in Japanese High-risk Hypertensive Patients? : a Subanalysis of CASE-J(Comprehensive Risk Management for Prevention of Coronary Artery Disease,Symposium 16 (SY-16) (H),The 73rd Annual Scientific
• Involvement of Cyrochrome P450 Metabolites in the Vascular Action of Angiotensin II on the Afferent Arterioles
• 腹膜透析患者に対する塩分コントロール指導の実態
• 腹膜透析患者の食塩コントロールに関する国内医学情報の網羅的検索
• 東北地域腹膜透析患者の, 減塩に対する意識・実際の食行動に関する調査
• Hepatocyte Growth Factor Stimulates Nitric Oxide Production through Endothelial Nitric Oxide Synthase Activation by the Phosphoinositide 3-Kinase/Akt Pathway and Possibly by Mitogen-Activated Protein Kinase Kinase in Vascular Endothelial Cells
• Relationship Between Coronary Events and Serum Cholesterol During 10 Years of Low-Dose Simvastatin Therapy : Long-Term Efficacy and Safety in Japanese Patients With Hypercholesterolemia in the Japan Lipid Intervention Trial (J-LIT) Extension 10 Study, a P
• Effects of Hypertension and Type 2 Diabetes Mellitus on the Risk of Total Cardiovascular Events in Japanese Patients with Hypercholesterolemia : Implications from the Japan Lipid Intervention Trial (J-LIT)
• Gender difference in coronary events in relation to risk factors in Japanese hypercholesterolemic patients treated with low-dose simvastatin
• The Risk of Cardiovascular Events in Japanese Hypertensive Patients with Hypercholesterolemia : Sub-Analysis of the Japan Lipid Intervention Trial (J-LIT) Study, a Large-Scale Observational Cohort Study
• Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia: Sub-analysis of the Japan Lipid Intervention Trial (J-LIT)
• Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients - Implication of the J-LIT study, a large scale nationwide cohort study
• Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia - Primary prevention cohort study of the Japan lipid intervention tri
• 原発性アルドステロン症診断におけるアルドステロン微量測定の意義
• 半月体性腎炎におけるbeta2 integrin 関与の病型間の相違について
• IgA腎症におけるメサンギウム細胞の形質転換と足細胞傷害との関連 : 経時生検例による検討
• 高カルシウム血症を合併した横紋筋融解症による急性腎不全の1例
• W-10-4 RPGNにおけるサイタフェレシス
• Variation in OSBPL10 is associated with dyslipidemia
• 3 Clinical Outcomes in Hypertensive Patients with High Cardiovascular Risks : Principal Results of Candesartan Antihyopertensive Survival Evaluation in Japan (CASE-J) Study(Late Breaking Clinical Trials in Japan, The 71st Annual Scientific Meeting of the
• The Optimal Target Blood Pressure for Antihypertensive Treatment in Japanese Elderly Patients with High-Risk Hypertension : A Subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial
• Rationale for Time-Qualified Reference Standards for 24-Hour Blood Pressure Values and Their Circadian Rhythms in Japanese Normotensive Adults : A Study by the Ambulatory Blood Pressure Monitoring Research Group
• The Importance of Home Blood Pressure Measurement for Preventing Stroke and Cardiovascular Disease in Hypertensive Patients : A Sub-Analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) Study, a Prospecti
• Impact of Blood Pressure Control on Cardiovascular Events in 26,512 Japanese Hypertensive Patients : The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) Study, a Prospective Nationwide Observational Study
• Efficacy and Safety of Long-Term Losartan Therapy Demonstrated by a Prospective Observational Study in Japanese Patients with Hypertension : The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) Study
• Design and Baseline Characteristics of an Observational Study in Japanese Patients with Hypertension : Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH)
• Valsartan in Elderly Isolated Systolic Hypertension (VALISH) Study : Rationale and Design
• A Case of Aldosterone-Producing Adrenocortical Adenoma Associated with a Probable Post-Operative Adrenal Crisis : Histopathological Analyses of the Adrenal Gland
• Inhibitory Effect of Chimera Decoy Oligodeoxynucleotides (ODN) against Ets and NFκ B on the Progression of Rabbit Experimental Aortic Aneurysms (AAA)
• The Aldehyde Dehydrogenase 2 Gene Is a Risk Factor for Hypertension in Japanese but Does Not Alter the Sensitivity to Pressor Effects of Alcohol : The Suita Study
• OJ-180 Association between Radial Augmentation Index and Early Systolic Left Ventricular Contraction in Hypertensive Patients with Normal Ejection Fraction(OJ30,Hypertension, Clinical (H),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of
• Epidemiological analysis of Metabolic Syndrome in Japan(Keynote Lecture, Preventive Medicine, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• GENETIC ASSOCIATION OF SUMO4 GENE, AS A CANDIDATE GENE FOR IDDM5, WITH SUSCEPTIBILITY TO TYPE 1 DIABETES IN ASIAN POPULATIONS
• Azelnidipine and Amlodipine: a Comparrison of Their Pharmacokinetics and Effects on Ambulatory Blood Pressure
• Hypertension and Risk Stratification
• Rationale, study design and implementation of the COLM study : the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients
• OJ-213 Homocys(e)ine is a Possible Risk Factor for Stroke in Japanese Patients with Coronary Artery Disease : The Brain and The Heart(Blood Coagulation/Fibrinolysis (IHD) : OJ24)(Oral Presentation (Japanese))
• -490- CONTRIBUTION OF AREA POSTREMA AND ANTEROVENTRAL THIRD VENTRICLE TO PRESSOR ACTIONS OF ANGIOTENSIN II IN DOGS
• Stimulatory Effects of Low-Dose 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Fluvastatin on Hepatocyte Growth Factor-Induced Angiogenesis : Involvement of p38 Mitogen-Activated Protein Kinase
• Expression of Peroxisome Proliferator-Activated Receptor Isoform Proteins in the Rat Kidney
• Transcription Suppression of Thromboxane Receptor Gene Expression by Retinoids in Vascular Smooth Muscle Cells
• Effects of Mitogen-Activated Protein Kinase Pathway and Co-Activator CREP-Binding Protein Peroxisome Proliferator-Activated Receptor-γ-Mediated Transcription Suppression of Angiotensin II Type 1 Receptor Gene
• Guidelines for Treatment of Hypertension in the Elderly : 2002 Revised Version
• Regulation of Cytochrome P-450 4A Activity by Peroxisome Proliferator-Activated Receptors in the Rat Kidney
• OJ-238 Determinants of Negative White Coat Effects in Medicated Hypertensives : Jichi Morning Hypertension Research (J-MORE) Study(Hypertension, clinical-4 (H) OJ40,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanes
• OE-141 Cardio-cerebral and Cardio-renal Complications in High-risk Hypertensive Patients with Cardiac Risks Based on the Results of CASE-J Trial(Hypertension, clinical(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Ci
• FRS-003 Prognostic Value of Left Ventricular Hypertrophy and Changes in Left Ventricular Mass in Hypertensive Patients : An analysis of CASE-J Trial(New Clinical Aspects for Hypertension(H),Featured Research Session,The 72nd Annual Scientific Meeting of t
• 1 To Make the Best Use of Japanese Evidences to Future Guidelines : From the Results and Experiences of CASE-J Trial(Symposium 18 (SY-18) (H) How can we Make the Best Use of Japanese Evidences for Future Guidelines,Special Program,The 72nd Annual Scientif
• evidence-based practice guideline for the treatment of chronic kidney disease
• Design and methods of a strategic outcome study for chronic kidney disease : Frontier of Renal Outcome Modifications in Japan
• Gene therapy for renal injury model rat using an adenovirus vector encoding the soluble rat Crry gene
• Different clinical outcomes for cardiovascular events and mortality in chronic kidney disease according to underlying renal disease : the Gonryo study
• Collagen Metabolism May be Involved in Arterial Stiffness Evaluated by Brachial-ankle Pulse Wave Velocity(Atherosclerosis, Clinical 6 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Cutoff Value of C-reactive Protein to Predict Multiple Silent Cerebral Infarcts in Japanese Older Hypertensives(Hypertension, Clinical 4 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• The Cutoff Value of CRP for Predicting Hypertension in a Japanese General Population : The JMS-Cohort Study(Preventive Medicine/Epidemiology/Education/Health Policy 3 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Guidelines for the Clinical Use of 24 Hour Ambulatory Blood Pressure Monitoring (ABPM) (JCS 2010) : Digest Version
• Guidelines for Smoking Cessation (JCS 2010) : Digest Version
• Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy : the Gonryo study
• Combination therapy for hypertension in the elderly : a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial
• Is renal antiaging possible?

もっと見る 閉じる

スポンサーリンク